Olema Pharmaceuticals Inc (OLMA) Insider Trading
- $55,572,919.13
- $50,028,224.99
- March 4, 2026
- Cyrus Harmon
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 19, 2021 | CTO | 12,000 | $24.97 | Sell | $299,640.00 | |
| Aug. 10, 2021 | Insider | 5,251 | $25.71 | Sell | $135,003.21 | |
| July 20, 2021 | CTO | 4,123 | $25.63 | Sell | $105,672.49 | |
| July 12, 2021 | Insider | 5,251 | $26.51 | Sell | $139,204.01 | |
| June 18, 2021 | CTO | 12,000 | $24.80 | Sell | $297,600.00 | |
| June 10, 2021 | Insider | 5,251 | $29.72 | Sell | $156,059.72 | |
| May 18, 2021 | Insider | 57,763 | $24.15 | Sell | $1,394,976.45 | |
| Nov. 23, 2020 | Director | 1,160,000 | $19.00 | Buy | $22,040,000.00 | |
| Nov. 23, 2020 | Major Shareholder | 425,000 | $19.00 | Buy | $8,075,000.00 |
Insiders are both buying and selling Olema Pharmaceuticals Inc stock.
The insider traders at Olema Pharmaceuticals Inc are: Cyrus Harmon, Kinney Horn, David C Myles, Sean Bohen, Bvf Partners L P/Il, Shawnte Mitchell, Biocapital Advisors L Paradigm, G. Walmsley Graham, Naseem Zojwalla, Cormorant Asset Management, Lp, and Bain Capital Life Sciences Inv
The most active insider trader at Olema Pharmaceuticals Inc is Cyrus Harmon with 28 trades.
Biocapital Advisors L Paradigm has sold the most Olema Pharmaceuticals Inc stock with a total value of $71,568,000.00.
G. Walmsley Graham has bought the most Olema Pharmaceuticals Inc stock with a total value of $44,080,000.00.
The most recent insider trade for Olema Pharmaceuticals Inc was on March 4, 2026.
The single biggest insider buy for Olema Pharmaceuticals Inc was from G. Walmsley Graham with a total value of $22,040,000.00 on Nov. 23, 2020.
The single biggest insider sell for Olema Pharmaceuticals Inc was from Biocapital Advisors L Paradigm with a total value of $35,784,000.00 on Aug. 1, 2024.